![Poul Sørensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Poul Sørensen is a Chief Scientific Officer at Allero Therapeutics BV.
He is on the Board of Directors at Graduate School of Immunology.
Dr. Sørensen was previously employed as a Senior Vice President-Strategic Development by Stallergenes SA.
| Companies | Position | Start |
|---|---|---|
Graduate School of Immunology
 Graduate School of Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Founder | - |
| Companies | Position | End |
|---|---|---|
| STALLERGENES | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Graduate School of Immunology
Graduate School of Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allero Therapeutics BV
Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
